Dose-Exploration Evaluating the Efficacy and Safety of Voclosporin in Subjects With Focal Segmental Glomerulosclerosis
Public ClinicalTrials.gov record NCT03598036. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-Label Dose-Exploration Cohort Study Evaluating the Efficacy and Safety of Voclosporin in Achieving Complete or Partial Remission of Proteinuria in Subjects With Focal Segmental Glomerulosclerosis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Evaluating the Efficacy and Safety of Voclosporin in Achieving Complete or Partial Remission of Proteinuria in Subjects with Focal Segmental Glomerulosclerosis
Study identification
- NCT ID
- NCT03598036
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 5 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 20, 2018
- Primary completion
- May 18, 2020
- Completion
- May 18, 2020
- Last update posted
- Sep 15, 2021
2018 – 2020
United States locations
- U.S. sites
- 21
- U.S. states
- 17
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| FSGS Investigative Center | Denver | Colorado | 80213 | — |
| FSGS Investigative Center | Winter Park | Florida | 32789 | — |
| FSGS Investigative Center | Lawrenceville | Georgia | 30046 | — |
| FSGS Investigative Center | Chicago | Illinois | 60611 | — |
| FSGS Investigative Center | Iowa City | Iowa | 52242 | — |
| FSGS Investigative Center | Louisville | Kentucky | 40202 | — |
| FSGS Investigative Center | Shreveport | Louisiana | 71101 | — |
| FSGS Investigative Center | Detroit | Michigan | 48201 | — |
| FSGS Investigative Center | Minneapolis | Minnesota | 55414 | — |
| FSGS Investigative Centre | St Louis | Missouri | 63110 | — |
| FSGS Investigative Center | Newark | New Jersey | 07103 | — |
| FSGS Investigative Center | New York | New York | 10032 | — |
| FSGS Investigative Center | Chapel Hill | North Carolina | 27599-7155 | — |
| FSGS Investigative Center | Charlotte | North Carolina | 28204 | — |
| FSGS Investigative Center | Columbus | Ohio | 43210 | — |
| FSGS Investigative Center | Bethlehem | Pennsylvania | 18017 | — |
| FSGS Investigative Center | Dallas | Texas | 75231 | — |
| FSGS Investigative Center | Dallas | Texas | 75246 | — |
| FSGS Investigative Center | El Paso | Texas | 79935 | — |
| FSGS Investigative Center | Houston | Texas | 77030 | — |
| FSGS Investigative Site | Salt Lake City | Utah | 84115 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03598036, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 15, 2021 · Synced Sep 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03598036 live on ClinicalTrials.gov.